Could These 2 Exciting COVID Stocks be 10-Baggers?

If you're looking for a stock with potential to rise 1,000%, you might find it in the coronavirus vaccine and treatment space. Let's take a look at two exciting players working on coronavirus treatments -- and see if they have what it takes to become tomorrow's stock-market winners. Humanigen (NASDAQ: HGEN) shares soared more than 54% in one trading session after the company reported positive results from its investigational monoclonal antibody treatment for hospitalized COVID-19 patients.